RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/19264766http://www.w3.org/2000/01/rdf-schema#comment"

Aims

CD36 has been shown to associate with non-receptor Src kinases to activate mitogen-activated protein kinases and trigger cytoskeletal remodelling, important events in foam cell formation and macrophage migration. Yet, its role in regulating circulating mononuclear phagocyte trafficking to atherosclerotic lesions has not been investigated. The aim of the present study was to investigate the role of CD36 in modulating the recruitment of mononuclear phagocytes to the arterial wall and the associated vascular inflammation, using both pharmacological and genetic approaches.

Methods and results

Apolipoprotein E-deficient (apoE(-/-)) mice fed a high-fat, high-cholesterol diet were treated daily with a CD36 ligand, EP 80317 (300 microg/kg), or 0.9% NaCl for 6 or 12 weeks. Forty-eight hours before sacrifice, mice were injected iv with (111)Indium-labelled macrophages. A 65% (P < 0.001) reduction of labelled macrophage accumulation at aortic lesions was observed in EP 80317-treated mice, mainly at the level of the aortic arch and iliac arteries, correlating with a 43% reduction of atherosclerotic lesion areas. This was associated with reduced phosphorylation of the focal adhesion kinase Pyk2 following stimulation with oxidized phospholipid in a Src kinase- and CD36-dependent manner. At the vascular level, EP 80317 treatment reduced the expression of pro-inflammatory proteins, including NADPH oxidase, inducible nitric oxide synthase, vascular endothelial cell adhesion molecule-1, and CCL2 chemokine. Plasma IL-6 levels were also reduced by 40% (P < 0.05). In contrast, none of these proteins was modulated in EP 80317-treated apoE/CD36 double knockout (apoE(-/-)/CD36(-/-)) mice.

Conclusion

Our results support a role for CD36 signalling in the regulation of mononuclear phagocyte trafficking to atherosclerotic-prone sites and in the associated vascular wall inflammation."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.org/dc/terms/identifier"doi:10.1093/cvr/cvp081"xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Febbraio M."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Ong H."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Sirois M.G."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Bujold K."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Harb D."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/author"Marleau S."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/date"2009"xsd:gYear
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/name"Cardiovasc Res"xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/pages"42-51"xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/title"The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation."xsd:string
http://purl.uniprot.org/citations/19264766http://purl.uniprot.org/core/volume"83"xsd:string
http://purl.uniprot.org/citations/19264766http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/19264766
http://purl.uniprot.org/citations/19264766http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/19264766
http://purl.uniprot.org/uniprot/#_E7D893-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q3U6Y9-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q08857-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q3UC79-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q3TA14-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q3UAI3-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q8C6Z4-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/#_Q9CT95-mappedCitation-19264766http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/19264766
http://purl.uniprot.org/uniprot/Q9CT95http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/19264766